Ultragenyx

Director, Commercial Lead Gene Therapy, EMEA

Ultragenyx  •  London, GB / Zürich, CH / Berlin, DE (Hybrid)  •  2 hours ago
Apply
AI can make mistakes so check important info. Chat history is never stored.

Job Description

Why Join Us?
Be a hero for our rare disease patients
At Ultragenyx, we fundamentally believe that taking real impactful action to care for the needs of patients and our people is always the right thing to do. To achieve this goal, our vision is to lead the future of rare disease medicine. For us, this means going where other biopharma companies won’t go – challenging the status quo and creating a new model that advances our field so more patients and caregivers can benefit from life-changing treatments. We do this by following the science, applying a novel rapid development approach, making innovative medicines at fair and reasonable prices, and creating a collaborative ecosystem to reach patients in ways that are most meaningful for them.
Our commitment and care for patients extends to our people, so culture is an essential cornerstone for Ultragenyx. We remain continuously focused on creating a supportive and inclusive environment of profound learning and growth – so employees can thrive in all areas of their lives, in and outside of work. Ultimately, we want to be an organization where we would be proud for our family, friends and children to work.
If you want to have a meaningful impact, do the best work of your career, and grow a lot, both professionally and personally, come join our team

ultradedicated – Your biggest challenges yield rare possibilities

As the Director, Commercial Lead, EMEA for assigned Gene Therapy products, you are the primary EMEA point of contact and accountable for translating global strategy into successful regional and local launch execution. You will lead cross-functional launch planning, country readiness, commercial execution, and launch performance across EMEA markets. Working closely with Global, regional, and country stakeholders, you will ensure launch readiness, patient access, operational excellence, and commercial success throughout the product lifecycle.

This role requires a deep understanding of the complexities involved in launching gene therapies, including regulatory, supply chain, and access challenges unique to these modalities.

Work Model:

Flex: This role will typically require onsite work 2-3 days each week, or more depending on business needs. In many locations, the business will set certain days each week that Flex employees are required to be onsite.

Responsibilities:

  • Lead the development and execution of EMEA pre-launch, launch, and post-launch plans, translating global strategy into market-specific execution frameworks across EMEA. 
  • Serve as the primary EMEA point of contact for assigned products, ensuring alignment across Global teams, regional functions, and country organizations throughout the launch journey. 
  • Partner with General Managers and country teams to develop local launch readiness plans, build capabilities, and incorporate market insights into regional plans. 
  • Lead the regional cross-functional launch team across Commercial, Medical, Market Access, Regulatory, Supply Chain, Quality, and Patient Advocacy to ensure coordinated and timely launch execution. 
  • Establish launch governance processes, readiness reviews, operational dashboards, and milestone tracking to manage risks and ensure execution excellence. 
  • Lead commercial readiness activities, including go-to-market planning, treatment-site readiness, and launch execution to support successful market entry and expansion. 
  • Partner with Market Access, Business Operations, Technical Operations, and Medical Affairs to support pricing, reimbursement, supply chain readiness, logistics planning, and treatment-site activation. 
  • Define and monitor launch KPIs and readiness metrics, proactively identifying risks and implementing corrective actions to achieve launch objectives
  • Drive launch performance reviews, operational improvement initiatives, and lessons-learned activities to strengthen future launch effectiveness across EMEA. 
  • Manage launch-related investments and budgets, supporting forecasting, business reviews, and leadership reporting while ensuring alignment with strategic priorities. 

Requirements:

Education

  • Bachelor’s degree in Business, Life Sciences, or a related field
  • Advanced degree such as PHd, MBA or MSc highly preferred

Skills and Competencies

  • Strategic thinker with a deep understanding of launch planning frameworks and operational execution in highly complex, cross-functional settings.
  • Exceptional leadership and stakeholder management skills in a matrixed, multicultural environment. Ability to lead end to end cross functional teams and inspire to execute.
  • Excellent project management, communication, and analytical skills.
  • Ability to anticipate and solve complex challenges with agility and strategic foresight.

Experience

  • 10+ years of pharmaceutical or biotech experience, including proven success launching products across multiple markets in EMEA.
  • Experience launching cell or gene therapies strongly preferred.
  • Rare or ultra-rare disease experience highly desirable.
  • Strong understanding of the complexities of end-to-end supply of Gene Therapies preferred.
  • Demonstrated experience with EMEA pricing, access (including early access), and regulatory environments, ideally in advanced therapy medicinal products (ATMPs).

Physical Demand Requirements:

  • Travel: As required to ensure launch optimization in countries and to enable best practice sharing
  • Full compliance with Ultragenyx policies, industry regulations, and applicable laws is required.

#LI-CK1 #LI-Hybrid

Full Time employees across the globe enjoy a range of benefits, including, but not limited to:
· Generous vacation time and public holidays observed by the company
· Volunteer days
· Long term incentive and Employee stock purchase plans or equivalent offerings
· Employee wellbeing benefits
· Fitness reimbursement
· Tuition sponsoring
· Professional development plans
* Benefits vary by region and country

Ultragenyx Pharmaceutical is an equal opportunity employer and prohibits unlawful discrimination based on race, color, religion, gender, sexual orientation, gender identity/expression, national origin/ancestry, age, disability, marital and veteran status, and any other status or classification protected by applicable federal, state, and/or local laws. Reasonable accommodation will be provided for all protected statuses or classifications protected by applicable law, including individuals with disabilities, disabled veterans, for pregnancy, childbirth, and related medical conditions, and based on sincerely held religious beliefs. Applicants can request an accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or in any part of the recruitment process, you may contact Talent Acquisition by emailing us at talentacquisition@ultragenyx.com

It is unlawful in Massachusetts to require or administer a lie detector test as a condition of employment or continued employment. An employer who violates this law shall be subject to criminal penalties and civil liability.

Note to External Recruiters All candidate activity and open positions are managed strictly through our Human Resources Department. Our Human Resources Department kindly requests that recruiters not contact employees/hiring managers directly in an attempt to solicit business and present candidates. Please note that failure to comply with this request will be a factor in determining a professional relationship with our organization. Submission of unsolicited resumes prior to an agreement set in place between the Human Resources Department and the recruiting agency will not create any implied obligation. Inquiries on developing a recruiting relationship with us, may be directed to talentacquisition@ultragenyx.com
Ultragenyx

About Ultragenyx

Leading with purpose. Every day.

“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and diverse clinical pipelines in rare disease. Our focus is on doing the right things for patients both during development and commercialization to deliver on the promise of these therapies in a way that's meaningful for rare disease communities.”

Emil D. Kakkis, M.D., Ph.D.

Chief Executive Officer and President

We have an inclusive culture of value and respect.

Ultragenyx brings novel products to those living with rare and ultrarare diseases with a focus on debilitating genetic diseases. Founded in 2010, we have rapidly built a diverse portfolio of approved therapies and products aimed at diseases with a high unmet medical need for which many have no approved therapies. It takes courage, care, talent, and dedication to make a meaningful impact for those living with rare diseases, their families and the rare disease community.

We put our people first, so they can take care of the rare disease community.

We purposefully cultivate and nurture a dynamic, supportive work environment where we encourage every team member to share their new ideas and help us unlock more possibilities. Our team is made up of exceptional and diverse people with a strong passion and commitment to helping those living with rare diseases. By embracing generosity, curiosity, inclusion, and humility we are constantly learning together—fostering an environment that supports profound growth and fulfillment.

If you want to have a meaningful impact, do the best work of your career while having fun and growing professionally and personally, come join our team!

Visit our community guidelines at: https://ultragenyx.co/community

Industry
Biotech & Life Sciences
Company Size
1,001-5,000 employees
Headquarters
Novato, California
Year Founded
2010
Social Media